adenine has been researched along with Hypertension, Portal in 3 studies
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nodular regenerative hyperplasia (NRH) leading to non-cirrhotic portal hypertension has been described in HIV-infected patients and has been linked to didanosine." | 3.77 | The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. ( Bénet, T; Billioud, C; Boibieux, A; Brochier, C; Chevallier, M; Cotte, L; Ferry, T; Miailhes, P; Scoazec, JY; Vanhems, P; Zoulim, F, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotte, L | 1 |
| Bénet, T | 1 |
| Billioud, C | 1 |
| Miailhes, P | 1 |
| Scoazec, JY | 1 |
| Ferry, T | 1 |
| Brochier, C | 1 |
| Boibieux, A | 1 |
| Vanhems, P | 1 |
| Chevallier, M | 1 |
| Zoulim, F | 1 |
| Schouten, JN | 1 |
| Van der Ende, ME | 1 |
| Koëter, T | 1 |
| Rossing, HH | 1 |
| Komuta, M | 1 |
| Verheij, J | 1 |
| van der Valk, M | 1 |
| Hansen, BE | 1 |
| Janssen, HL | 1 |
| Spiering, W | 1 |
| Kroon, AA | 1 |
| de Leeuw, PW | 1 |
3 other studies available for adenine and Hypertension, Portal
| Article | Year |
|---|---|
The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Didano | 2011 |
Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension.
Topics: Adenine; Adult; Anti-HIV Agents; Case-Control Studies; Chemical and Drug Induced Liver Injury; Didan | 2012 |
A116C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
Topics: Adenine; Alleles; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Cytosine; Heart | 2005 |